European Pharmaceutical Review

MAY 22, 2023

A review by Swedish researchers has identified the benefits of smart contracts on blockchain platforms in the pharmaceutical supply chain and its role in combating counterfeit drugs. Blockchain offers the possibility of non-modifiable data uploading with traceability and low-cost data storage. In conclusion, Kordestani et al.

92

92

pharmaphorum

APRIL 14, 2022

million price tag. million if paid through an outcomes-based contract for patients with sustained transfusion independence.” US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its proposed $2.1

FDA 64

FDA 64

Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. The UK is followed by Australia, an early adopter of risk-sharing, and the US, where risk-sharing mechanisms have increased in popularity due to the evolving complexity of the contracts.

FDA 105

FDA 105

pharmaphorum

JANUARY 21, 2022

This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.

Insurance 52

Insurance Vaccines 52

The Checkup by Singlecare

DECEMBER 20, 2022

Oxybutynin is an antispasmodic and anticholinergic drug, which relaxes smooth muscles in the bladder by blocking acetylcholine, the chemical that signals muscles to contract. . Available in both prescription and nonprescription formats, oxybutynin helps relieve urinary incontinence and frequent or urgent urination due to overactive bladder.

Insurance 52

Insurance Insurance Coverage Dosage 52

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. But there is a silver lining.

Vaccines 90

Vaccines 90

pharmaphorum

NOVEMBER 19, 2021

Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. It’s understood the prices have increased in new supply contracts, possibly by as much as a quarter. However, Europe has decided not to renew AZ’s contract next year, preferring to focus on the slightly more efficacious mRNA jabs.

Vaccines 136

Vaccines Communication 136